High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol.

Sheikh S AbdullahNeda RostamzadehFlory T MuandaEric McArthurMatthew A WeirJessica M SontropRichard B KimSedig KamranAmit X Garg

Published in: Canadian journal of kidney health and disease (2024)

This accelerated approach to conducting postmarket drug-safety studies has the potential to more efficiently detect drug-safety signals in a vulnerable population. The results of this protocol may ultimately help improve medication safety.

Keyphrases

chronic kidney disease
high throughput
adverse drug
randomized controlled trial
healthcare
end stage renal disease
case control
emergency department
physical activity
single cell
risk assessment
drug induced